AI assistant
Sending…
Active Biotech — Major Shareholding Notification 2013
Mar 11, 2013
3133_iss_2013-03-11_415ad580-1b44-4395-ab30-eb926f07570b.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
Issuer Active Biotech AB (publ)
Holder
Investor AB
Instrument
| Instrument | Aktier SE0001137985 | |
|---|---|---|
| Before the transaction | ||
| Shares | 0 | |
| Voting rights | 0 | |
| Transaction | ||
| Reason for major shareholding notification New share issue | ||
| Date | 11/03/2013 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 6,000,000 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 6,000,000 | |
| Percentage | ||
| Directly held shares | 8 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 8 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares |
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
-
Physically settled
-
Cash settled
Total
Chain of controlling companies
Voting rights % Voting rights Company
6,000,000 8 Duba AB Group total holdings
Voting rights 6,000,000 Percentage of voting rights 8
Notes (other relevant informations according to law)
Kommentar: Investor AB har genom sitt helägda dotterbolag Duba AB förvärvat 8,0 procent av aktierna i Active Biotech AB.
Published
11/03/2013 13:53
Contact
Name Emil Hedberg
Phone 08-55319060 Email [email protected]
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Active Biotech
Quarterly Report
2026
May 7
Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 17
Annual Report (ESEF)
2026
Apr 1
Audit Report / Information
2026
Feb 12
Audit Report / Information
2026
Feb 12
Share Issue/Capital Change
2026
Jan 30
Share Issue/Capital Change
2026
Jan 30
Regulatory Filings
2026
Jan 21